Because Smyd3 is highly expressed in many types of cancers and plays critical roles in cell cycle alteration, apoptosis, and EMT [43, 68–70], increased ERα-SMYD3 signaling before, during, and post pregnancy could significantly contribute to PABC and breast cancer formation in general. Here, SMYD3 is linked to breast cancer.